Prof. G. K Rath
Head, National Cancer Institute-India (NCI-India), Jhajjar, Haryana
Chief, Dr. B.R. Ambedkar Institute-Rotary Cancer Hospital
Professor, Dept of Radiation Oncology
All India Institute of Medical Sciences,
New Delhi, Ansari Nagar-110029, India
Dr. Goura Kishor Rath is the Head of the newly established National Cancer Institute-India (NCI-India), All India Institute of Medical Sciences (AIIMS), New Delhi, currently under construction in Jhajjar, Haryana. Once built, the NCI will be a unique institution devoted to the translational research and treatment of cancer, and the training of the next generation of scientists and physicians dedicated to eradicating cancer in the nation. Dr. Rath is a highly decorated scientist and physician. He took his MBBS at Utkal University in Orissa, later receiving his M.D. in Radiotherapy from AIIMS, New Delhi. His specialties are in radiation oncology, gynecological and breast cancer, and brachytherapy. He was named Chief of the Dr. B.R. Ambedkar Institute-Rotary Cancer Hospital since 2007 and named as Head of the NCI at AIIMS-II Campus at Jhajjar in March 2014. Among his many awards and honors, he has received a Lifetime Achievement Award from the Association of Radian Oncologists of India, and recipient of the “Hindustan Bhushan” for outstanding contribution in improving Health Services. In addition, he has participated in numerous conferences, committees and delegations on behalf of the Government of India. He serves on the Governing Bodies of four Regional Cancer Centers in Bikaner, Allahabad, Cuttack and Agartala, and is the Chairman of the selection committee for the new AIIMS in Bhopal, as well as Chairman of the Expert Committee designing the NCI at Jhajjar. Dr. Rath also serves on the editorial board of several oncology journals and textbooks, as well as author of 37 book chapters and hundreds of journal articles.
It is a proud moment to update you all that the national cancer institute(NCI), in Jhajjar Haryana is the largest public funded health care project in independent india costing nearly 2035 crore rupees. The institute will bridge the gap for cancer healthcare, providing state of art facility to the patients. It will be the largest institute which will pioneer in the field of translational research for giving better treatment options and modalities. It will concentrate on the various unanswered questions through research regarding prevention, early diagnosis and management of Indian cancer like the oral cancers, gall bladder cancer, cervical cancers etc. We are collaborating with the national institute of cancer of usa, la foundation de I’ Academie de Medicine of France, Barts Cancer Institute in Queen Mary University of London in UK and many more national and international organizations to carry out high quality research. It will engage scientists from medical, bioinformatics, molecular medicine background to ensure quality research output. When functional, the institute will open doors and provide career and job opportunity to nearly 3500 individuals.